Johnson & Johnson has a potential alternative to eye drops with its drug-eluting Acuvue Theravision contact lens.
As far back as the early 1960s, researchers toyed with the idea of delivering medication through contact lenses.
Johnson & Johnson Vision (NYSE:JNJ) Director of Clinica Science Dr. Brian Pall told Drug Delivery Business News that patents back then disclosed how a soft contact lens of hydrogel material could be an effective vehicle for delivering medication to the eye.
Get the full story at our sister site, Drug Delivery Business News.
Filed Under: Drug Delivery
![A display of DNA sequencing output from an automated ABI 373 sequencer. [National Human Genome Research Institute (NHGRI)]](https://www.drugdiscoverytrends.com/wp-content/uploads/2024/06/51187236177_b7b566a401_k-268x170.jpg)
